//
Dual GLP-1/GIP receptor agonist for metabolic research
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
Tirzepatide is a synthetic dual agonist that activates both GLP-1 and GIP receptors through a single peptide molecule. This dual-incretin mechanism has generated significant scientific interest for its multi-pathway approach to metabolic regulation research.
Phase 3 SURPASS trials demonstrated tirzepatide's differentiated receptor pharmacology, with researchers noting additive effects from combined GLP-1 and GIP pathway co-activation in metabolic studies.
Price comparison based on publicly available data. Competitor prices may vary.
Store in refrigerator at 4°C, tightly sealed, away from heat, light and moisture.. Keep frozen until ready to reconstitute.
Use sterile water for injection. Allow to reach room temperature before reconstitution.
Stable for 24 months when stored properly. Once reconstituted, use within 30 days.